Wall Street is not clueless. Missling has spent years meeting with analysts and investors, presenting at investor conferences, and participating in scientific conferences. Media coverage, while not like BIIB, has been good for a tiny, early stage company like Anavex. Problem is, Wall Street has heard the story and but remains skeptical.